M. Gasior et al., ANTICONVULSANT AND BEHAVIORAL-EFFECTS OF NEUROACTIVE STEROIDS ALONE AND IN CONJUNCTION WITH DIAZEPAM, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 543-553
Epilepsy continues to be a significant clinical problem as current med
ications neither adequately control seizures nor are free of untoward
side-effects. Modulation of the neuroactive steroid site on the gamma-
aminobutyric acid (GABA)(A) receptor complex may be an important new d
irection for pharmaceutical interventions in epilepsy. In this study w
e evaluated the protective actions of four neuroactive steroids, 3 alp
ha-hydroxy-5 alpha-pregnan-20-one, the 3 beta-methylated analog, ganax
olone (3 alpha-hydroxy-3 beta-methyl-5 alpha-pregnan-20-one), 3 alpha-
hydroxy-5 beta-pregnan-20-one and Co 2-1068 (3 beta-(4acetylphenyl)eth
ynyl-3 alpha,21-dihydroxy-5 beta-20-one-21-hemisuccinate), against sev
eral standard convulsive tests in male, Swiss-Webster mice. Consistent
with their GABAergic actions, the neuroactive steroids as well as dia
zepam and phenobarbital dose-dependently protected against clonic conv
ulsions induced by pentylenetetrazol; the N-methyl-D-aspartate recepto
r antagonist, dizocilipine, was ineffective. In contrast to diazepam a
nd phenobarbital, however, all of the neuroactive steroids and dizocli
pine produced full protection against cocaine-induced convulsions. Som
e of the neuroactive steroids, as well as dizocilpine, were efficaciou
s against the seizures and lethality induced by N-methyl-D-aspartate.
Pregnenolone, a steroid devoid of GABAergic activity, was not effectiv
e in any of the convulsant models. Although all of the compounds produ
ced motor toxicity in high doses as measured by the inverted-screen te
st, the neuroactive steroids demonstrated an equivalent or improved se
paration between anticonvulsant potency and motoric impairment. Inacti
ve doses of the neuroactive steroids markedly enhanced the anticonvuls
ant effects of diazepam against pentylenetetrazol without significantl
y increasing motor toxicity. This adjunct treatment resulted in protec
tive indices ranging from 60 to 360 compared to 12 for diazepam alone.
The distinct profile of anticonvulsant activity of the neuroactive st
eroids may be related to their combined actions on gamma-aminobutyric
acid, N-methyl-D-aspartate receptors, or voltage-operated Ca++ channel
s. These results help to define the neuroactive steroids as a novel cl
ass of antiepileptic agents and suggest their potential in clinical pr
actice.